
Larnox LA350 mg
Beximco Pharmaceuticals Ltd.
Aminophylline is a methylxanthine bronchodilator used in the management of reversible airway obstruction.
Aminophylline is a methylxanthine bronchodilator used in the management of reversible airway obstruction. Its use is classified by strength of evidence as follows:
Aminophylline is intended to be used together with, not instead of, inhaled bronchodilators and corticosteroids; it is not first-line therapy for acute asthma or COPD exacerbations.
Aminophylline has been used off-label for apnea of prematurity and to aid diuresis in certain settings, but such uses require specialist supervision and are not FDA-approved indications.
Dosing of Aminophylline must be individualized based on indication, age, smoking status, hepatic/cardiac status, concomitant medications, and serum theophylline concentration monitoring.
| Patient group | Loading dose | Maintenance infusion |
|---|---|---|
| Adults not on theophylline therapy | ~5.7 mg/kg Aminophylline IV over 20-30 minutes | ~0.5 mg/kg/hour (non-smoking adults) |
| Children 1-9 years | Weight-based, per protocol | ~1.0 mg/kg/hour |
| Elderly / hepatic impairment / heart failure | Same loading dose principle | Reduced infusion rate; requires closer monitoring |
Serum theophylline concentration should be measured before increasing the infusion rate and periodically during therapy; the infusion should be slowed or stopped immediately if signs of toxicity occur.
Oral Aminophylline may be used for maintenance therapy in selected patients with chronic asthma or COPD, with the dose titrated based on clinical response and, where available, serum level monitoring, under a physician's supervision.
Renal impairment does not usually require dose adjustment, since theophylline is primarily eliminated hepatically; hepatic impairment, however, requires dose reduction and closer monitoring.
Side effects of Aminophylline are largely dose- and serum-concentration related.
Rarely, exfoliative dermatitis has been reported, generally in patients previously sensitized to ethylenediamine. Because toxicity can occur even within or near the therapeutic range in susceptible patients, any new or worsening symptoms during Aminophylline therapy should be reported to a physician promptly.
Aminophylline is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.